Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Lactobacillus brevis SBC8803 and Reduced Inflammation

Research synthesisVery low evidenceModerate effect5 studies · 5 beneficial · 0 neutral · 0 harmful

Across 5 studies, all reported beneficial effects of Lactobacillus brevis SBC8803 on reduced inflammation, with a predominant effect size of moderate. The evidence includes one randomized controlled trial showing a moderate, statistically significant benefit on exercise-induced inflammation in healthy adults. Most studies are reviews or preclinical, and no consistent dose range or form was reported.

  • Studied populations: Healthy adults, people with IBD

Caveats: Available evidence is overwhelmingly positive — clinical literature in this area is subject to publication bias (null-result studies are less likely to be published or indexed). Evidence base is small (only 5 studies) — conclusions should be considered preliminary. Only one study (an RCT) reported statistical significance, and several included studies did not directly test Lactobacillus brevis SBC8803 specifically, limiting the strength of inference.

Generated Jul 11, 2026
8 of 8 papers
Back to top